# Study of CT001 in Healthy Volunteers

> **NCT04807335** · PHASE1 · COMPLETED · sponsor: **Cessatech A/S** · enrollment: 14 (actual)

## Conditions studied

- Bioavailability

## Interventions

- **DRUG:** CT001
- **DRUG:** Ketamine
- **DRUG:** sufentanil

## Key facts

- **NCT ID:** NCT04807335
- **Lead sponsor:** Cessatech A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-17
- **Primary completion:** 2021-06-02
- **Final completion:** 2021-06-02
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2021-08-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04807335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04807335, "Study of CT001 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04807335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*